Related Experiment Video
Updated: Aug 2, 2025

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics
Published on: September 19, 2016
Vandetanib
Ahmed I Al-Ghusn1, Ahmed H Bakheit2, Mohamed W Attwa1
1Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Vandetanib is an FDA-approved anti-cancer drug for medullary thyroid carcinoma. This review covers its properties, applications, synthesis, and analytical methods for accurate measurement.
Area of Science:
- Pharmacology
- Oncology
- Analytical Chemistry
Background:
- Vandetanib is an antineoplastic kinase inhibitor approved by the FDA in 2011.
- It treats adults with specific types of medullary thyroid carcinoma.
- Contraindicated in patients with serious cardiac conditions due to Q-T interval prolongation risk.
Purpose of the Study:
- To provide a comprehensive overview of Vandetanib.
- To detail its physical, molecular, and pharmacological properties.
- To summarize synthesis, analytical measurement techniques, and characterization of raw materials.
Main Methods:
- Literature review of Vandetanib's properties, action, and pharmacokinetics.
- Compilation of reported Vandetanib measurement techniques.
- Summary of synthesis and characterization methods.
Main Results:
- Vandetanib's mechanism of action as a kinase inhibitor.
- Established applications in medullary thyroid carcinoma treatment.
- Overview of various analytical techniques for Vandetanib quantification.
- Details on synthesis pathways and raw material characterization.
Conclusions:
- Vandetanib is a key therapeutic agent for medullary thyroid carcinoma.
- Understanding its analytical methods is crucial for routine analysis.
- Comprehensive knowledge of its synthesis and properties aids in drug development and quality control.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Related Concept Videos
Regulation of Water Intake
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Thiazide-Class Diuretics
Renal Drug Excretion: Tubular Reabsorption